Standard Biotools (LAB) Operating Income (2016 - 2025)
Historic Operating Income for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$32.9 million.
- Standard Biotools' Operating Income fell 2336.79% to -$32.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.4 million, marking a year-over-year decrease of 1942.57%. This contributed to the annual value of -$175.2 million for FY2024, which is 12876.76% down from last year.
- According to the latest figures from Q3 2025, Standard Biotools' Operating Income is -$32.9 million, which was down 2336.79% from -$25.7 million recorded in Q2 2025.
- Standard Biotools' Operating Income's 5-year high stood at -$11.3 million during Q4 2021, with a 5-year trough of -$73.8 million in Q4 2024.
- Over the past 5 years, Standard Biotools' median Operating Income value was -$25.7 million (recorded in 2025), while the average stood at -$28.6 million.
- Per our database at Business Quant, Standard Biotools' Operating Income soared by 5475.2% in 2023 and then tumbled by 26269.51% in 2024.
- Standard Biotools' Operating Income (Quarter) stood at -$11.3 million in 2021, then crashed by 87.51% to -$21.1 million in 2022, then fell by 1.3% to -$21.4 million in 2023, then crashed by 245.24% to -$73.8 million in 2024, then soared by 55.39% to -$32.9 million in 2025.
- Its Operating Income was -$32.9 million in Q3 2025, compared to -$25.7 million in Q2 2025 and -$33.0 million in Q1 2025.